Effect of denosumab on prolonging bone-metastasis-free survival (BMFS) in men with nonmetastatic castrate-resistant prostate cancer (CRPC) presenting with aggressive PSA kinetics. Background: The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback